American Research & Management Company’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $193K | Sell |
2,024
-150
| -7% | -$14.8K | 0.05% | 119 |
|
|
2022
Q2 | $201K | Sell |
2,174
-286
| -12% | -$27.9K | 0.05% | 122 |
|
|
2022
Q1 | $249K | Buy |
2,460
+47
| +2% | +$4.94K | 0.05% | 121 |
|
|
2021
Q4 | $249K | Buy |
2,413
+100
| +4% | +$9.24K | 0.05% | 125 |
|
|
2021
Q3 | $196K | Hold |
2,313
| – | – | 0.05% | 130 |
|
|
2021
Q2 | $193K | Hold |
2,313
| – | – | 0.04% | 132 |
|
|
2021
Q1 | $174K | Hold |
2,313
| – | – | 0.04% | 135 |
|
|
2020
Q4 | $158K | Sell |
2,313
-40
| -2% | -$2.6K | 0.04% | 137 |
|
|
2020
Q3 | $137K | Buy |
2,353
+44
| +2% | +$2.74K | 0.04% | 128 |
|
|
2020
Q2 | $150K | Hold |
2,309
| – | – | 0.05% | 132 |
|
|
2020
Q1 | $137K | Hold |
2,309
| – | – | 0.05% | 125 |
|
|
2019
Q4 | $172K | Sell |
2,309
-386
| -14% | -$27.1K | 0.05% | 131 |
|
|
2019
Q3 | $170K | Buy |
2,695
+250
| +10% | +$14.8K | 0.05% | 132 |
|
|
2019
Q2 | $133K | Hold |
2,445
| – | – | 0.04% | 148 |
|
|
2019
Q1 | $132K | Buy |
2,445
+1,908
| +355% | +$118K | 0.04% | 152 |
|
|
2018
Q4 | $35K | Hold |
537
| – | – | 0.01% | 194 |
|
|
2018
Q3 | $42K | Hold |
537
| – | – | 0.01% | 200 |
|
|
2018
Q2 | $35K | Hold |
537
| – | – | 0.01% | 196 |
|
|
2018
Q1 | $33K | Hold |
537
| – | – | 0.01% | 211 |
|
|
2017
Q4 | $39K | Hold |
537
| – | – | 0.01% | 217 |
|
|
2017
Q3 | $44K | Hold |
537
| – | – | 0.01% | 193 |
|
|
2017
Q2 | $43K | Hold |
537
| – | – | 0.01% | 182 |
|
|
2017
Q1 | $42K | Buy |
537
+527
| +5,270% | +$42.1K | 0.01% | 175 |
|
|
2016
Q4 | $1K | Hold |
10
| – | – | ﹤0.01% | 340 |
|
|
2016
Q3 | $1K | Hold |
10
| – | – | ﹤0.01% | 350 |
|
|
2016
Q2 | $1K | Hold |
10
| – | – | ﹤0.01% | 339 |
|
|
2016
Q1 | $1K | Hold |
10
| – | – | ﹤0.01% | 354 |
|
|
2015
Q4 | $1K | Hold |
10
| – | – | ﹤0.01% | 355 |
|
|
2015
Q3 | $1K | Hold |
10
| – | – | ﹤0.01% | 363 |
|
|
2015
Q2 | $1K | Hold |
10
| – | – | ﹤0.01% | 375 |
|
|
2015
Q1 | $1K | Hold |
10
| – | – | ﹤0.01% | 355 |
|
|
2014
Q4 | $1K | Sell |
10
-215
| -96% | -$18.9K | ﹤0.01% | 351 |
|
|
2014
Q3 | $18K | Hold |
225
| – | – | 0.01% | 244 |
|
|
2014
Q2 | $17K | Hold |
225
| – | – | 0.01% | 260 |
|
|
2014
Q1 | $17K | Hold |
225
| – | – | 0.01% | 261 |
|
|
2013
Q4 | $16K | Hold |
225
| – | – | 0.01% | 261 |
|
|
2013
Q3 | $13K | Hold |
225
| – | – | 0.01% | 266 |
|
|
2013
Q2 | $13K | Buy |
+225
| New | +$13K | 0.01% | 262 |
|
Other funds holding CVS
American Research & Management Company's CVS Position: Q3 2022 in Review
American Research & Management Company reduced its CVS Health (CVS) stake by 6.9% in Q3 2022, selling an estimated $14.8K and leaving 2,024 shares worth $193K. The position accounts for 0.05% of the portfolio, ranked #119.
American Research & Management Company first reported a position in CVS in Q2 2013 and has held it in 38 quarters since. The position peaked at $249K in Q1 2022. 2,325 funds tracked by Wall St. Rank hold CVS as of Q3 2022.
- American Research & Management Company held 2,024 shares of CVS Health worth $193K as of Q3 2022.
- American Research & Management Company sold 150 CVS Health shares in Q3 2022, an estimated $14.8K.
- CVS Health made up 0.05% of American Research & Management Company's portfolio in Q3 2022, its #119 holding.
- American Research & Management Company first reported a position in CVS Health in Q2 2013 and has held it in 38 quarters since.
- American Research & Management Company's CVS Health position peaked at $249K in Q1 2022.
- 2,325 funds tracked by Wall St. Rank held CVS Health as of Q3 2022.
Based on American Research & Management Company's 13F filing for Q3 2022, filed 7 Oct 2022.